Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Zhejiang Cancer Hospital
Kind Pharmaceuticals LLC
Kind Pharmaceuticals LLC
M.D. Anderson Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Boston Children's Hospital
Masonic Cancer Center, University of Minnesota
Beth Israel Deaconess Medical Center
Centre Henri Becquerel
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center